Wang Zhan, Hu Rui, Zhu Rui, Lu Wenlong, Wei Guanghao, Zhao Jing, Gu Zhi-Yuan, Zhao Qing
State Key Lab for Mesoscopic Physics and Frontiers Science Center for Nano-optoelectronics, Electron Microscopy Laboratory, School of Physics, Peking University, Beijing, 100871, China.
Jiangsu Collaborative Innovation Center of Biomedical Functional Materials, Jiangsu Key Laboratory of New Power Batteries, College of Chemistry and Materials Science, Nanjing Normal University, Nanjing, 210023, China.
Small Methods. 2022 Nov;6(11):e2200743. doi: 10.1002/smtd.202200743. Epub 2022 Oct 10.
The ability to detect biomolecules at the single-molecule level is at the forefront of biological research, precision medicine, and early diagnosis. Recently, solid-state nanopore sensors have emerged as a promising technique for label-free and precise diagnosis assay. However, insufficient sensitivity and selectivity for small analytes are a great challenge for clinical diagnosis applications via solid-state nanopores. Here, for the first time, a metal-organic cage, PCC-57, is employed as a carrier to increase the sensitivity and selectivity of solid-state nanopores based on the intrinsic interaction of the nanocage with biomolecules. Firstly, it is found that the carrier itself is undetectable unless bound with the target analytes and used oligonucleotides as linkers to attach PCC-57 and target analytes. Secondly, two small analytes, oligonucleotide conjugated angiopep-2 and polyphosphoric acid, are successfully distinguished using the molecular carrier. Finally, selectivity of nanopore detection is achieved by attaching PCC-57 to oligonucleotide-tailed aptamers, and the human alpha-thrombin sample is successfully detected. It is believed that the highly designable metal-organic cage could serve as a rich carrier repository for a variety of biomolecules, facilitating single-molecule screening of clinically relevant biomolecules based on solid-state nanopores in the future.
在单分子水平检测生物分子的能力处于生物研究、精准医学和早期诊断的前沿。最近,固态纳米孔传感器已成为一种有前途的无标记精确诊断检测技术。然而,对于小分子分析物而言,灵敏度和选择性不足是通过固态纳米孔进行临床诊断应用面临的巨大挑战。在此,首次将金属有机笼PCC-57用作载体,基于纳米笼与生物分子的内在相互作用来提高固态纳米孔的灵敏度和选择性。首先,发现除非与目标分析物结合并使用寡核苷酸作为连接物来连接PCC-57和目标分析物,否则载体本身无法被检测到。其次,使用分子载体成功区分了两种小分子分析物,即寡核苷酸偶联的血管生成素-2和多磷酸。最后,通过将PCC-57连接到寡核苷酸尾端适配体上实现了纳米孔检测的选择性,并成功检测了人α-凝血酶样品。人们认为,这种高度可设计的金属有机笼可作为各种生物分子的丰富载体库,有助于未来基于固态纳米孔对临床相关生物分子进行单分子筛选。